Latest stories on HOWL
Werewolf Therapeutics GAAP EPS of $0.08 beats by $0.40, revenue of $21M
Seeking Alpha68 · bullishearnings
Werewolf Therapeutics, Inc. (HOWL) files 8-K
SEC 8-K50 · neutralgeneral
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
Business Insider55 · neutralearnings